Top Markets
Coin of the day
SQZ Biotechnologies Company SQZ Biotechnologies Company

SQZ Biotechnologies Company

SQZ
Classificação em ações #38924
SQZ Biotechnologies, a biotechnology firm currently in the clinical development... SQZ Biotechnologies, a biotechnology firm currently in the clinical development phase, is focused on creating cell-based therapies for various severe ailments, including cancerous growths, autoimmune disorders, and infectious diseases. Its primary experimental therapeutic, known as SQZ-PBMC-HPV, is derived from its SQZ Antigen Presenting Cells technology. This treatment is currently undergoing Phase I clinical trials, both as a standalone therapy and alongside other immune-oncology treatments, to address advanced or metastatic solid tumors positive for HPV16, encompassing cancers of the cervix, head-and-neck, anus, penis, vulva, and vagina. Furthermore, the company is progressing with SQZ-AAC-HPV, another Phase I clinical candidate targeting the same HPV16+ advanced or metastatic solid tumors, which is also being evaluated as a single agent and in conjunction with other immune-modulating agents. Beyond these, SQZ Biotechnologies is also advancing its SQZ Activating Antigen Carriers and SQZ Tolerizing Antigen Carriers platforms. Established in 2013, the company operates from its main office in Watertown, Massachusetts.
Preço da ação
$0.05083
Última sincronização: 2023-09-01
Valor de mercado
$732.57K
Variação (1 dia)
8.15%
Variação (1 ano)
0.00%
País
US
Negociar SQZ Biotechnologies Company (SQZ)

Categoria

Histórico de desdobramentos de ações de SQZ Biotechnologies Company (SQZ)
As ações SQZ Biotechnologies Company (símbolo: SQZ) passaram por um total de 0 desdobramentos.
O desdobramento mais recente ocorreu em Aug 14, 2026.
Uma ação SQZ comprada antes de Aug 14, 2026 equivaleria hoje a 0 ações SQZ.
Lista de desdobramentos de ações
Ano Desdobramento Multiplicador Multiplicador cumulativo
Não há dados suficientes para as datas fornecidas.
Desdobramentos de ações de empresas semelhantes ou concorrentes
Empresa Número de desdobramentos de ações Multiplicador cumulativo País
1 x2
US
0 -
NL
0 -
CH
0 -
KR
0 -
BE